SCM
BDSX icon

Soleus Capital Management’s Biodesix BDSX Stock Holding History

Soleus Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.04M Buy
+416,599
New +$5.16M 0.24% 60
2024
Q4 		– Sell
-201,903
Closed -$7.19M – 88
2024
Q3 		$7.19M Sell
201,903
-103,695
-34% -$3.57M 0.56% 47
2024
Q2 		$9.35M Buy
+305,598
New +$8.73M 0.82% 40

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Soleus Capital Management's BDSX Position: Q1 2026 in Review

Soleus Capital Management opened a new position in Biodesix (BDSX) in Q1 2026: 416,599 shares worth $6.04M. The stake represents 0.24% of the portfolio and ranks #60 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in BDSX as recently as Q3 2024.

Soleus Capital Management first reported a position in BDSX in Q2 2024 and has held it in 3 quarters since. The position peaked at $9.35M in Q2 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Soleus Capital Management held 416,599 shares of Biodesix worth $6.04M as of Q1 2026.
  • Biodesix was a new Soleus Capital Management position in Q1 2026.
  • Biodesix made up 0.24% of Soleus Capital Management's portfolio in Q1 2026, its #60 holding.
  • Soleus Capital Management first reported a position in Biodesix in Q2 2024 and has held it in 3 quarters since.
  • Soleus Capital Management's Biodesix position peaked at $9.35M in Q2 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.